Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera

References

• Schaefer, A. (1984). Bleeding and thrombosis in the myeloproliferative disorders. Blood, 64, 1–12.
   PubMed Web of Science ®Google Scholar
• Barbui, C., Cortelazzo, S., Viero, P., Bassan, R., Dini, E. and Semeraro, N. (1983). Thrombohemorragic complications in 101 cases of myeloproloferative disorders: relationship to platelet number and function. Eur J Cancer Clin Oncol., 19, 1593–99.
   PubMedGoogle Scholar
• Bellucci, S., Janvier, M., Tobelem, G., Flandrin, G., Charpak, Y., Berger, R. and Boiron, M. (1986). Essential thrombocytemias. Clinical evolutionary and biological data. Cancer, 58, 2440–7.
   PubMed Web of Science ®Google Scholar
• Landolfi, R., Rocca, B. and Patrono, C. (1995). Bleending and thrombosis in myeloproliferative disorders: mechanism and treatment. Critical Reviews Oncol Haematol., 20, 203–22.
   PubMed Web of Science ®Google Scholar
• Regev, A., Stark, P., Blickstein, D. and Lahav, M. (1997). Thrombotic complications in essential thrombocythemia with relatively low platelet counts. Am J Hematol., 56, 168–72.
   PubMed Web of Science ®Google Scholar
• Chong, B. H., Murray, B., Berndt, M. C., Dunlop, L. C., Brighton, T. and Chesterman, C. N. (1994). Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood, 83, 1535–41.
   PubMed Web of Science ®Google Scholar
• Katayama, H., Handa, M. and Araki, Y. (1993). Soluble P selectin is present in normal circulation and its plasma levels is elevated in patients with thrombotic thrombocytopenic purpura and haemolitic uremic syndrome. Br J Haematol, 84, 702–10.
   PubMed Web of Science ®Google Scholar
• Blann, Ad, Amiral, J. and Me Collum, Cn. (1996). Endothelial cell markers and the prediction of cardiovascular events. Br J Haematol, 93, A692.
   Google Scholar
• Jilma, B., Fasching, P., Ruthuer, C., Rumplmayr, A., Ruzicka, S., Kapiotis, S., Wagner, O. F. and Eichler, H. G. (1996). Elevated circulating P-selectin in insulin depen-dent diabetes mellitus. Thromb Haemost, 76, 328–32.
   PubMed Web of Science ®Google Scholar
• Blann, A. D., Faragher, E. B. and Mc Collum, C. N. (1997). Increased soluble p-selectin following myocardial infarction: a new marker for the progression of atherosclerosis. Blood coagulation and Fibrinolysis, 8, 383–90.
   PubMed Web of Science ®Google Scholar
• Gearing, A. J. H., Haemingway, I., Piggot, R., Hughes, J., Rees, A. J. and Cashman, S. J. (1992). Soluble forms of vascular adhesion molecules E-selectin, ICAM-1 and VCAM-1: pathological significance. ANN NY Acad Sci, 667, 324–31.
   PubMed Web of Science ®Google Scholar
• Blann, A. D., Tse, W., Maxwell, S. R. J. and Waite, M. A. (1994). Increased levels of the soluble adhesion molecule E-selectin in essential hypertension, j Hypert, 12, 925–8.
   PubMed Web of Science ®Google Scholar
• Morishita, E., Masanari, S. and Asakura, H. (1992). Increased levels of plasma thrombomodulin in chronic myelogenous leukemia. Am J Hematol, 39, 183–7.
   PubMed Web of Science ®Google Scholar
• Wada, H., Ohiwa, M., Kaneko, T., Tamaki, S., Tanigawa, M., Shirakawa, S., Koyama, M., Hayeshi, T. and Suzuki, K. (1992). Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation. Am J Hematol, 39, 20–4.
   PubMed Web of Science ®Google Scholar
• Ohdama, S. and Aoki, N. (1997). Increase of plasma thrombomodulin in systemic vasculitis. Thromb Haemost, 77, 609.
   PubMed Web of Science ®Google Scholar
• Ishii, H. and Majerua, P. W. (1985). Thrombomodulin is present in human plasma and urine. J Clin Invest, 76, 2178–84.
   PubMed Web of Science ®Google Scholar
• Ishii, H., Uchiyama, H. and Kazama, M. (1991). Soluble thrombomodulin antigen in conditionated medium is increased by damage of endothelial cells. Thromb Haemost, 65, 618–23.
   PubMed Web of Science ®Google Scholar
• Berlin, N. (1975). Diagnosis and classification of the polycythemias. Semin Hematol., 12, 339–51.
   PubMed Web of Science ®Google Scholar
• Bucalossi, A., Marotta, G., Bigazzi, G., Galieni, P. and Dispensa, E. (1996). Reduction of antithrombin III., protein C and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with thrombosis. Am J Hematol., 52, 14–20.
   PubMed Web of Science ®Google Scholar
• Kornberg, A., Rahimi-Levene, N., Yoma, R., Mor, A. and Rachmilewitz, E. A. (1997). Enhanced generation of monocyte tissue factor and increased plasma prothrombin fragment1+2 levels in patients with polycythemia vera: mechanism of activation of blood coagulation. Am J Hematol., 56, 5–11.
   PubMed Web of Science ®Google Scholar
• Bellucci, S., Ignatova, E., Jaillet, N. and Boffa, M. C. (1993). Platelet hyperactivation in patients with essential thrombocythemia is not associated with vascular endothelial cell damage as judged by the level of plasma thrombomodulin, protein S., PAI-1, t-PA and vWF. Thromb Haemost., 70, 736–42.
   PubMed Web of Science ®Google Scholar
• Musolino, C., Alonci, A., Allegra, A., Spatari, G., Bellomo, G., Tringali, O., Quartarone, C., Squadrito, G. and Quartarone, M. (1998). Increased levels of soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications. Am J Hematol., 57, 109–12.
   PubMed Web of Science ®Google Scholar
• Boeme, M. W., Schmitt, W. H., Youinou, P., Stremmel, W. R. and Gross, W. L. (1996). Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides. Am J Med., 101, 387–94.
   PubMed Web of Science ®Google Scholar
• Wada, H., Ohiwa, M. and Kaneko, T. (1992). Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation. Am J Hematol, 39, 20–4.
   PubMed Web of Science ®Google Scholar
• Tamaka, A., Ishii, H., Hiraishi, S., Kamaja, M. and Meezawa, H. (1991). Increased thrombomodulin values in plasma of diabetic men with microangiopathy. Clin Chem., 37, 269–72.
   PubMed Web of Science ®Google Scholar